Novavax, Inc.
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015
DGAP-News: Novavax, Inc. 2015-04-30 / 22:05 --------------------------------------------------------------------- GAITHERSBURG, Md., 2015-04-30 22:05 CEST (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its first quarter 2015 financial and operating results after the close of U.S. financial markets on Thursday, May 7, 2015. In addition, management will host a conference call to discuss the quarterly results and provide an update on corporate activities. Conference call details are as follows: Date: May 7, 2015 Time: 4:30 pm US Eastern Time Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Via web: www.novavax.com, 'Investor Info'/'Events' Conference call replay: Dates: Starting at 7:30 pm ET on May 7, 2015 until midnight May 14, 2015 Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) Passcode: 35660022 Via web: www.novavax.com, 'Investor Info'/'Events' About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for ground-breaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the company's website, www.novavax.com. CONTACT: Novavax, Inc. Barclay A. Phillips SVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Senior Manager, Investor Relations ir@novavax.com 240-268-2000 Russo Partners, LLC David Schull Todd Davenport, Ph.D. david.schull@russopartnersllc.com todd.davenport@russopartnersllc.com 212-845-4271 News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-04-30 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Novavax, Inc. United States ISIN: US6700021040 End of News DGAP News-Service --------------------------------------------------------------------- 351999 2015-04-30
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden